NASDAQ: DCOY
Decoy Therapeutics Inc Stock Ownership - Who owns Decoy Therapeutics?

Insider buying vs selling

Have Decoy Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arnold C. HanishDirector2025-12-3015$0.64
$9.60Sell
Arnold C. HanishDirector2025-12-3012$0.64
$7.68Sell
Arnold C. HanishDirector2025-11-205,000$0.75
$3.74kBuy
Mark J. RosenblumExec VP Finance CFO2025-11-2020,000$0.80
$16.00kBuy

1 of 1

DCOY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DCOY insiders and whales buy or sell their stock.

DCOY Shareholders

What type of owners hold Decoy Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christoph H. Westphal1,701.23%8,310,759$68.65MInsider
Boston Foundation Inc450.34%2,200,000$18.17MInsider
Roderick MacKinnon88.28%431,277$3.56MInsider
Jonathan P. Northrup72.20%352,713$2.91MInsider
Barton Pk LLC20.47%100,000$826.00kInsider
John Sculley12.10%59,111$488.26kInsider
Thomas 1. Wessel11.68%57,064$471.35kInsider
David J. Arthur10.06%49,135$405.86kInsider
Scott Jordan6.47%31,609$261.09kInsider
Warberg Asset Management LLC5.73%28,000$231.28kInstitution

1 of 3

DCOY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DCOY0.67%99.33%Net BuyingNet Selling
MBRX1.47%98.53%Net Buying
OGEN0.54%99.46%Net SellingNet Selling
GRI2.12%97.88%
MTNB1.45%98.55%

Decoy Therapeutics Stock Ownership FAQ

Who owns Decoy Therapeutics?

Decoy Therapeutics (NASDAQ: DCOY) is owned by 16.22% institutional shareholders, 2,389.24% Decoy Therapeutics insiders, and 0.00% retail investors. Christoph H. Westphal is the largest individual Decoy Therapeutics shareholder, owning 8.31M shares representing 1,701.23% of the company. Christoph H. Westphal's Decoy Therapeutics shares are currently valued at $68.65M.

If you're new to stock investing, here's how to buy Decoy Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.